Skip to content
healthcare.dev
Get a free key

Magnilife Psoriasis Care

NDC 43689-0036, GRAPHITE, DAPHNE MEZEREUM BARK,, cream, from The Magni Group, Inc..

Product NDC
43689-0036
Status
Listed
Labeler
The Magni Group, Inc.
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43689-0036 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GRAPHITE3 [hp_X]/g
  • DAPHNE MEZEREUM BARK6 [hp_X]/g
Package NDCNDC-11Package
43689-0036-2436890036021 JAR in 1 BOTTLE, UNIT-DOSE (43689-0036-2) / 56 g in 1 JAR

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 43689-0036 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43689-0036 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43689-0036. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.